FN2 Earnings Intelligence
Repligen Corporation financials
Repligen Corporation (RGEN) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $603.8 | $523.5 | $751.3 | $757.4 | $566 |
| + Debt | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - |
| Revenue | $670.5 | $801.5 | $632.4 | $634.4 | $738.3 |
| % Growth | 83.1% | 19.5% | -21.1% | 0.3% | 16.4% |
| Gross Profit | $391.3 | $455.7 | $278.4 | $274.6 | $386.2 |
| % Margin | 58.3% | 56.9% | 44.0% | 43.3% | 52.3% |
| EBITDA | $205.7 | $275.7 | $116.3 | $34.6 | $133.9 |
| % Margin | 30.7% | 34.4% | 18.4% | 5.4% | 18.1% |
| Net Income | $128.3 | $186 | $35.6 | -$25.5 | $48.9 |
| % Margin | 19.1% | 23.2% | 5.6% | -4.0% | 6.6% |
| Diluted EPS | $2.24 | $3.24 | $0.63 | -$0.46 | $0.86 |
| % Growth | 101.8% | 44.6% | -80.6% | -173.0% | 287.0% |
| Operating Cash Flow | $119 | $172.1 | $113.9 | $175.4 | $117.4 |
| CapEx | $67.1 | $84.8 | $36.2 | $25.7 | $23.5 |
| Free Cash Flow | $51.9 | $87.2 | $77.7 | $149.7 | $93.9 |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue | $670.5 | $801.5 | $632.4 | $634.4 | $738.3 |
| Gross Profit | $391.3 | $455.7 | $278.4 | $274.6 | $386.2 |
| EBITDA | $205.7 | $275.7 | $116.3 | $34.6 | $133.9 |
| Net Income | $128.3 | $186 | $35.6 | -$25.5 | $48.9 |
| Diluted EPS | $2.24 | $3.24 | $0.63 | -$0.46 | $0.86 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $603.8 | $523.5 | $751.3 | $757.4 | $566 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $255.3 | $284.6 | $510.1 | $525.6 | $542.2 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $119 | $172.1 | $113.9 | $175.4 | $117.4 |
| Capital Expenditure | $67.1 | $84.8 | $36.2 | $25.7 | $23.5 |
| Free Cash Flow | $51.9 | $87.2 | $77.7 | $149.7 | $93.9 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 83.1% | 19.5% | -21.1% | 0.3% | 16.4% |
| Gross Margin | 58.3% | 56.9% | 44.0% | 43.3% | 52.3% |
| EBITDA Margin | 30.7% | 34.4% | 18.4% | 5.4% | 18.1% |
| Net Margin | 19.1% | 23.2% | 5.6% | -4.0% | 6.6% |
| FCF Margin | 7.7% | 10.9% | 12.3% | 23.6% | 12.7% |
| Diluted EPS Growth | 101.8% | 44.6% | -80.6% | -173.0% | 287.0% |
Get the RGEN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.